Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review
Sharma Sonali,Bipul Ray,Hediyal Ahmed Tousif,Annan Gopinath Rathipriya,Tuladhar Sunanda,Arehally M. Mahalakshmi,Wiramon Rungratanawanich,Musthafa Mohamed Essa,M. Walid Qoronfleh,Saravana Babu Chidambaram,Byoung-Joon Song
DOI: https://doi.org/10.3390/cells11081362
IF: 6
2022-04-16
Cells
Abstract:Depression is a highly common mental disorder, which is often multifactorial with sex, genetic, environmental, and/or psychological causes. Recent advancements in biomedical research have demonstrated a clear correlation between gut dysbiosis (GD) or gut microbial dysbiosis and the development of anxiety or depressive behaviors. The gut microbiome communicates with the brain through the neural, immune, and metabolic pathways, either directly (via vagal nerves) or indirectly (via gut- and microbial-derived metabolites as well as gut hormones and endocrine peptides, including peptide YY, pancreatic polypeptide, neuropeptide Y, cholecystokinin, corticotropin-releasing factor, glucagon-like peptide, oxytocin, and ghrelin). Maintaining healthy gut microbiota (GM) is now being recognized as important for brain health through the use of probiotics, prebiotics, synbiotics, fecal microbial transplantation (FMT), etc. A few approaches exert antidepressant effects via restoring GM and hypothalamus–pituitary–adrenal (HPA) axis functions. In this review, we have summarized the etiopathogenic link between gut dysbiosis and depression with preclinical and clinical evidence. In addition, we have collated information on the recent therapies and supplements, such as probiotics, prebiotics, short-chain fatty acids, and vitamin B12, omega-3 fatty acids, etc., which target the gut–brain axis (GBA) for the effective management of depressive behavior and anxiety.
cell biology